Literature DB >> 2824595

Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing's disease?

A R Hermus1, G F Pieters, G J Pesman, E Meijer, A G Smals, T J Benraad, P W Kloppenborg.   

Abstract

The type of secondary adrenal failure, which occurs after successful pituitary surgery in Cushing's disease was studied using CRH administration. Eight patients with Cushing's disease were studied in the immediate postoperative period (9-18 days) of successful pituitary surgery. The results in these patients were compared with those in 13 healthy subjects, 7 patients with secondary adrenal failure of the pituitary type and 9 patients with secondary adrenal failure of the hypothalamic type. In all postoperative patients with Cushing's disease, except one, clear ACTH and cortisol responses occurred after CRH, demonstrating hypothalamic adrenal failure in these patients. This demonstration of hypothalamic adrenal failure after neurosurgery strongly argues against a pivotal role for endogenous CRH in the pathogenesis of Cushing's disease in these patients. The mean ACTH response to CRH in the postoperative patients with Cushing's disease was significantly lower than that in patients with adrenal failure of the hypothalamic type. This suggests the presence of pituitary failure in the postadenomectomy patients. In conclusion, this study provides arguments that the secondary adrenal failure after adenomectomy in Cushing's disease is caused by both hypothalamic and pituitary failure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824595     DOI: 10.1007/BF03348149

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas.

Authors:  J B Tyrrell; R M Brooks; P A Fitzgerald; P B Cofoid; P H Forsham; C B Wilson
Journal:  N Engl J Med       Date:  1978-04-06       Impact factor: 91.245

2.  Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin.

Authors:  P A Fitzgerald; D C Aron; J W Findling; R M Brooks; C B Wilson; P H Forsham; J B Tyrrell
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

3.  Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.

Authors:  T Tsukada; Y Nakai; T Koh; S Tsujii; M Inada; M Nishikawa; H Shinoda; I Kawai; N Takezawa; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

4.  Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.

Authors:  G F Pieters; A G Smals; H J Goverde; G J Pesman; E Meyer; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

5.  Anterior pituitary hormones in plasma and pituitaries from patients with Cushing's disease.

Authors:  T Suda; H Demura; R Demura; K Jibiki; F Tozawa; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

6.  Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.

Authors:  D N Orth; C R DeBold; G S DeCherney; R V Jackson; A N Alexander; J Rivier; C Rivier; J Spiess; W Vale
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

7.  Immunoreactive corticotropin-releasing factor in human plasma.

Authors:  T Suda; N Tomori; F Yajima; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.

Authors:  G P Chrousos; H M Schulte; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

9.  Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis.

Authors:  O A Müller; H G Dörr; B Hagen; G K Stalla; K von Werder
Journal:  Klin Wochenschr       Date:  1982-12-15

10.  Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.

Authors:  A Kuwayama; N Kageyama; T Nakane; M Watanabe; N Kanie
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

View more
  1 in total

1.  Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Authors:  Alessandro Prete; Rosa Maria Paragliola; Filomena Bottiglieri; Carlo Antonio Rota; Alfredo Pontecorvi; Roberto Salvatori; Salvatore Maria Corsello
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.